These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19783154)

  • 1. RAGE, glomerulosclerosis and proteinuria: roles in podocytes and endothelial cells.
    D'Agati V; Yan SF; Ramasamy R; Schmidt AM
    Trends Endocrinol Metab; 2010 Jan; 21(1):50-6. PubMed ID: 19783154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy.
    Wendt TM; Tanji N; Guo J; Kislinger TR; Qu W; Lu Y; Bucciarelli LG; Rong LL; Moser B; Markowitz GS; Stein G; Bierhaus A; Liliensiek B; Arnold B; Nawroth PP; Stern DM; D'Agati VD; Schmidt AM
    Am J Pathol; 2003 Apr; 162(4):1123-37. PubMed ID: 12651605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin.
    Myint KM; Yamamoto Y; Doi T; Kato I; Harashima A; Yonekura H; Watanabe T; Shinohara H; Takeuchi M; Tsuneyama K; Hashimoto N; Asano M; Takasawa S; Okamoto H; Yamamoto H
    Diabetes; 2006 Sep; 55(9):2510-22. PubMed ID: 16936199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of receptor for advanced glycation end-products and signalling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes.
    Gu L; Hagiwara S; Fan Q; Tanimoto M; Kobata M; Yamashita M; Nishitani T; Gohda T; Ni Z; Qian J; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2006 Feb; 21(2):299-313. PubMed ID: 16263740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II upregulates RAGE expression on podocytes: role of AT2 receptors.
    Rüster C; Bondeva T; Franke S; Tanaka N; Yamamoto H; Wolf G
    Am J Nephrol; 2009; 29(6):538-50. PubMed ID: 19129693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.
    Yamamoto Y; Kato I; Doi T; Yonekura H; Ohashi S; Takeuchi M; Watanabe T; Yamagishi S; Sakurai S; Takasawa S; Okamoto H; Yamamoto H
    J Clin Invest; 2001 Jul; 108(2):261-8. PubMed ID: 11457879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies.
    Daroux M; Prévost G; Maillard-Lefebvre H; Gaxatte C; D'Agati VD; Schmidt AM; Boulanger E
    Diabetes Metab; 2010 Feb; 36(1):1-10. PubMed ID: 19932633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction.
    Rüster C; Franke S; Wenzel U; Schmidthaupt R; Fraune C; Krebs C; Wolf G
    Am J Nephrol; 2011; 34(4):309-17. PubMed ID: 21846974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
    Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of receptors for advanced glycosylated end-products in renal disease.
    Abel M; Ritthaler U; Zhang Y; Deng Y; Schmidt AM; Greten J; Sernau T; Wahl P; Andrassy K; Ritz E
    Nephrol Dial Transplant; 1995; 10(9):1662-7. PubMed ID: 8559486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia.
    Davis B; Dei Cas A; Long DA; White KE; Hayward A; Ku CH; Woolf AS; Bilous R; Viberti G; Gnudi L
    J Am Soc Nephrol; 2007 Aug; 18(8):2320-9. PubMed ID: 17625119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.
    Wilkinson L; Gilbert T; Kinna G; Ruta LA; Pennisi D; Kett M; Little MH
    J Am Soc Nephrol; 2007 Jun; 18(6):1697-708. PubMed ID: 17460146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for advanced glycation end products is a promising target of diabetic nephropathy.
    Yamamoto Y; Doi T; Kato I; Shinohara H; Sakurai S; Yonekura H; Watanabe T; Myint KM; Harashima A; Takeuchi M; Takasawa S; Okamoto H; Hashimoto N; Asano M; Yamamoto H
    Ann N Y Acad Sci; 2005 Jun; 1043():562-6. PubMed ID: 16037279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE mediates podocyte injury in adriamycin-induced glomerulosclerosis.
    Guo J; Ananthakrishnan R; Qu W; Lu Y; Reiniger N; Zeng S; Ma W; Rosario R; Yan SF; Ramasamy R; D'Agati V; Schmidt AM
    J Am Soc Nephrol; 2008 May; 19(5):961-72. PubMed ID: 18256352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte hypertrophy in diabetic nephropathy.
    Kim NH
    Nephrology (Carlton); 2005 Oct; 10 Suppl():S14-6. PubMed ID: 16174280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor.
    Chuang PY; Yu Q; Fang W; Uribarri J; He JC
    Kidney Int; 2007 Oct; 72(8):965-76. PubMed ID: 17667983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.
    Wendt T; Tanji N; Guo J; Hudson BI; Bierhaus A; Ramasamy R; Arnold B; Nawroth PP; Yan SF; D'Agati V; Schmidt AM
    J Am Soc Nephrol; 2003 May; 14(5):1383-95. PubMed ID: 12707408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
    Yamagishi S; Takeuchi M
    Drugs Exp Clin Res; 2004; 30(4):169-75. PubMed ID: 15553663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAGE: a novel biological and genetic marker for vascular disease.
    Kalea AZ; Schmidt AM; Hudson BI
    Clin Sci (Lond); 2009 Apr; 116(8):621-37. PubMed ID: 19275767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.